Abstract:Background Emerging studies revealed that cancer stem cells (CSCs) possessed peculiar metabolic properties, which however remained largely unknown in hepatocellular carcinoma (HCC). Genetic silencing of liver-abundant miR-192-5p was a key feature for multiple groups of CSC-positive HCCs. We thus aimed to investigate essential metabolic features of hepatic CSCs via using HCCs with miR-192-5p silencing as a model. Methods Datasets from two independent HCC cohorts were used. Data integration analyses of miR-192-5p with metabolome and mRNA transcriptome data in HCC Cohort 1 were performed to investigate miR-192-5p related metabolic features, which was further validated in Cohort 2. Cellular and molecular assays were performed to examine whether and how miR-192-5p regulated the identified metabolic features. Co-culture systems consisting of HCC cells and LX2 (human hepatic stellate cell line) or THP1 (human monocyte cell line) were established to explore effects of the identified metabolic properties on stemness features of HCC cells via interacting with co-cultured non-tumor cells. Results High levels of glycolysis-related metabolites and genes were present in HCCs with low miR-192-5p and CSC-positive HCCs in two independent HCC cohorts. miR-192-5p knockout cells displayed CSC features and miR-192-5p loss led to an enhanced glycolytic phenotype via upregulating three bona fide targets, GLUT1 and PFKFB3 (two glycolytic enzymes) and c-Myc (regulating glycolytic genes’ expression). Meanwhile, c-Myc suppressed miR-192-5p transcription, ensuring a low-miR-192-5p/high-c-Myc loop to maintain hyperglycolysis. Moreover, over-produced lactic acid from hyperglycolytic HCC cells stimulated the ERK phosphorylation of co-cultured LX2 and THP1 non-tumor cells partially via NDRG3 and MCT1, which in turn promoted cell malignancy and stemness of HCC cells. Consistently, HCC patients with low level of miR-192-5p in their tumor tissues and high level of NDRG3 or MCT1 in their non-tumor tissues had the shortest overall survival. Conclusions In CSC-positive HCCs, miR-192-5p loss enhanced glycolysis and over produced lactate might further increase HCC malignant features via interacting with environmental non-tumor cells.

Mir-202 Mediates Metabolic Shift in Lung Cancer Cells Via Targeting HK2

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

miR-206 regulates a metabolic switch in nasopharyngeal carcinoma by suppressing HK2 expression

Loss of MiR-192-5p Initiates a Hyperglycolysis and Stemness Positive Feedback in Hepatocellular Carcinoma.

Mir-139-5p Inhibits Aerobic Glycolysis, Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma Via a Reciprocal Regulatory Interaction with ETS1

The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma

Loss of MiR-192 Initiates a Hyperglycolysis and Stemness Positive Feedback in Hepatocellular Carcinoma

MicroRNA-202 suppresses glycolysis of pancreatic cancer by targeting hexokinase 2

MicroRNA-143 (Mir-143) Regulates Cancer Glycolysis Via Targeting Hexokinase 2 Gene.

Mir-142-3p Inhibits Aerobic Glycolysis and Cell Proliferation in Hepatocellular Carcinoma Via Targeting LDHA

Downregulating Microrna-144 Mediates A Metabolic Shift in Lung Cancer Cells by Regulating Glut1 Expression

Mitochondrial Mir-181A-5p Promotes Glucose Metabolism Reprogramming in Liver Cancer by Regulating the Electron Transport Chain.

A Novel Mir-155/Mir-143 Cascade Controls Glycolysis by Regulating Hexokinase 2 in Breast Cancer Cells.

Mir-122 Targets Pyruvate Kinase M2 and Affects Metabolism of Hepatocellular Carcinoma

MiR‐199a‐5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer

LncRNA MIR17HG Promotes Colorectal Cancer Liver Metastasis by Mediating a Glycolysis-Associated Positive Feedback Circuit

Suppression of Mir-199a Maturation by Hur is Crucial for Hypoxia-Induced Glycolytic Switch in Hepatocellular Carcinoma

Mutual Regulation Of Mir-199a-5p And Hif-1 Alpha Modulates The Warburg Effect In Hepatocellular Carcinoma

Mineralocorticoid Receptor Suppresses Cancer Progression and the Warburg Effect by Modulating the Mir-338-3p-Pklr Axis in Hepatocellular Carcinoma

MiR-216a-5p/Hexokinase 2 Axis Regulates Uveal Melanoma Growth Through Modulation of Warburg Effect

[Mir-181C Inhibits Glycolysis by Targeting Hexokinase 2 in Cancer-Associated Fibroblasts].